In clinical phase II studies. the efficacy of a promising therapy is tested in patients for the first time. Based on the results. it is decided whether the development programme should be stopped or whether the benefit-risk profile is promising enough to justify the initiation of large phase III studies. https://www.markbroyard.com/hot-save-turbo-air-m3f24-1-n-29-wide-m3-series-reach-in-freezer-featuring-one-solid-door-energy-star-on-sale-top-super/